研究结果表明：（1）通过先合成小分子药物单体，再进行聚合得到高分子载体药物的途径是可行的，且可使携药量得到极大程度的增加。
The results show as follows:(1)It is feasible to obtain polymeric carrier drugs by synthesizing unsaturated drug monomers firstly, then self-polymerizing and co-polymerizing them.
医用纳米高分子作为药物、基因传递和控释的载体，是一种新型的控释体系。
As a new drug and gene delivery carrier, medical polymer nanoparticles appear to be very promising and have been widely studied.
综述了可生物降解的高分子材料聚天各酰胺及其衍生物作为载体在药物控制释放中的应用。
The USES of biodegradable polymers poly-asparagine and its derivatives, as carriers in controlled drug release are reviewed.
目的：探讨壳聚糖在脑组织中的生物相容性，以期为临床提供可用于颅内植入化疗的药物缓释高分子载体。
OBJECTIVE:To explore the biocompatibility of chitosan in brain tissues in order to provide slow released macromolecule carrier for clinically used chemotherapy.
可生物降解高分子材料具有良好的生物相容性。聚合物和降解产物对机体毒副作用小，已成为微球等新药物剂型的重要载体材料。
Biodegradable polymer materials had good biocompatibility. Polymer and degradation product had small toxicity to the body, which become new drug major carriers of microsphere formulations.
生物可降解型高分子载体控制释放药物和生物可降解型高分子载体靶向药物是近年来高分子药物研究的重点。
Biodegradable macromolecule carried controlled drug releasing and biodegradable macromolecule carried targeted drug delivery are the focus of recent investigation in macromolecular medicine.
药物的控制释放体系是生物医用材料研究领域的重要课题，其支撑点是要有性能良好的高分子药物载体。
The controlled drug release systems are an important research field in biomedical materials applications. Its effectiveness largely depends on the good properties of drug carriers.
药物的控制释放体系是生物医用材料研究领域的重要课题，其支撑点是要有性能良好的高分子药物载体。
The controlled drug release systems are an important research field in biomedical materials applications. Its effectiveness largely depends on the good properties of drug carriers.
应用推荐